Best hematologist-oncologists in Israel: TOP 28 doctors

Head of Hematology at Sourasky Medical Center – Israel's premier hospital for blood cancer care.

• 24 years of experience specializing in hematology and oncology
• Fellowship-trained at Ronald O Perelman and Claudia Cohen Centre
• Expert in bone marrow transplants and advanced cellular therapies
• Published 90+ research articles in leading medical journals

Several hundred stem cell transplants performed – Dr. Ram specializes in complex hematologic cases at Sourasky Medical Center.

• Triple board-certified in Hematology, Medical Oncology, and Internal Medicine
• Fellowship-trained at New York Medical College
• Published over 30 scientific articles and a textbook chapter
• Focuses on allogenic and haploidentical transplant techniques

300+ pediatric bone marrow and umbilical blood transplants – Dr. El Hasid leads the Pediatric Oncohematology Department at Dana Dwek Children's Hospital.

• Specializes exclusively in pediatric transplant procedures
• Published 50+ research papers on hematology topics
• Trained at City of Hope Hospital in Los Angeles
• Member of American Association for Hematology

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

900+ bone marrow transplants performed – Dr. Michael Shapira is a leading hematologist at Sourasky Medical Center.

• Specialized in bone marrow transplantation at Hadassah Medical Center
• Recognized for advancing transplantation medicine
• Speaks English and Hebrew fluently
• Graduated from Hebrew University medical school

Dr. Dror Levin directs pediatric hematology oncology at Sourasky Medical Center – specializing in blood cancers and sarcomas in children.

• Expert in pediatric bone marrow transplantation and CAR T-cell therapy
• Trained at Rizzoli Orthopaedic Institute – a global leader in bone oncology
• Coordinates Israel's sarcoma treatment programs for children
• Member of the Israel Society of Pediatric Hematology-Oncology (ISPHO)

Dr. Kirshner leads phase III clinical trials for resistant cancers at Sourasky Medical Center, bringing cutting-edge treatments to patients.

• Double fellowship-trained in hematology and medical oncology at Montefiore
• Specializes in treatment-resistant follicular lymphoma and aplastic anemia
• Fellow of the American Society of Hematology
• Over 32 years of experience of experience in hematology oncology
• Board-certified in internal medicine and oncology

Head of Hemato-Oncology Institute at Sourasky Medical Center – Dr. Aviv specializes in complex blood cancers and bone marrow transplants.

• 34 years of experience focused exclusively on oncohematology
• Leads the Bone Marrow Transplantation Department
• Expert in CAR T-cell therapy and immunotherapy
• Practices at Israel's premier cancer center

Dr. Herishanu Yair is a leading hematologist with 10+ awards for groundbreaking research in chronic lymphocytic leukemia (CLL) at Sourasky Medical Center.

• Specializes in CLL – the most common adult leukemia
• Recipient of the prestigious Klitzberg Oncology Award
• Member of both Israeli and American Hematology Associations
• Extensive training at top Israeli medical institutions
• Published researcher with grants from Israeli Science Foundation

Forbes-listed as one of Israel's best doctors – Dr. Goldstein leads Pediatric Oncology at Hadassah Medical Center.

• Specializes in pediatric hemato-oncology for over 27 years of experience
• Expert in retinoblastoma and precision medicine approaches
• Performs haploidentical bone marrow transplants for children
• Member of four international pediatric oncology associations

Prof. Reuven Or leads the Department of Hematology and Bone Marrow Transplantation at Hadassah – a pioneer in cancer immunotherapy and cell therapy.

• specializing in bone marrow transplants and hematologic cancers
• Medical Director of Israel's National Blood Bank and Public Bone Marrow Registry
• Recipient of the prestigious Menachem Begin Prize for medical achievements
• Trained at top institutions in Italy and the US
• Published multiple research articles in medical journals

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.